RBC Capital Maintains Outperform Rating for Thermo Fisher Scientific: Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
RBC Capital has reaffirmed its Outperform rating for Thermo Fisher Scientific (TMO) and increased its price target from $592.00 to $642.00, indicating a potential 18.69% upside from the current share price of $540.89. Thermo Fisher Scientific is a leading provider of scientific instruments, laboratory equipment, diagnostics consumables, and life science reagents, operating across four segments.
February 01, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital maintains Outperform rating for Thermo Fisher Scientific with a raised price target from $592 to $642, suggesting a significant upside potential.
The reaffirmation of the Outperform rating and the increase in price target by RBC Capital are strong indicators of Thermo Fisher Scientific's robust market position and growth potential. Given the company's diverse product offerings and significant role in the scientific and laboratory equipment sectors, the raised price target reflects confidence in its future performance. This analysis is based on the current share price and the potential for an 18.69% increase, which could positively impact investor sentiment and stock price in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100